Nicolas Mottet

Active 1999–2025

101
Papers
26,504
Citations
57
h-index
94
i10-index

Citations

Citations per year for Nicolas Mottet1985: 1 citations1999: 2 citations2000: 1 citations2001: 2 citations2002: 4 citations2003: 4 citations2004: 6 citations2005: 4 citations2006: 8 citations2007: 11 citations2008: 11 citations2009: 12 citations2010: 16 citations2011: 54 citations2012: 122 citations2013: 119 citations2014: 138 citations2015: 144 citations2016: 150 citations2017: 169 citations2018: 195 citations2019: 840 citations2020: 930 citations2021: 945 citations2022: 805 citations2023: 561 citations2024: 966 citations2025: 327 citations2026: 16 citations1986–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,562 citing papers, 14.6% of this breakdownItaly: 907 citing papers, 8.5% of this breakdownGermany: 850 citing papers, 8% of this breakdownUnited Kingdom: 792 citing papers, 7.4% of this breakdownChina: 741 citing papers, 6.9% of this breakdownNetherlands: 572 citing papers, 5.4% of this breakdownFrance: 530 citing papers, 5% of this breakdownCanada: 491 citing papers, 4.6% of this breakdownBelgium: 369 citing papers, 3.5% of this breakdownSwitzerland: 355 citing papers, 3.3% of this breakdownAustralia: 323 citing papers, 3% of this breakdownSpain: 288 citing papers, 2.7% of this breakdown
0%14.6%Other 27.1%

Fields

  • Medicine86.2%
  • Biochemistry, Genetics and Molecular Biology8.2%
  • Computer Science1%
  • Engineering1%
  • Immunology and Microbiology0.9%
  • Neuroscience0.5%
  • Other2.2%

Topics

  • Prostate Cancer Diagnosis and Treatment20.8%
  • Prostate Cancer Treatment and Research20.7%
  • Radiopharmaceutical Chemistry and Applications4.1%
  • Advanced Radiotherapy Techniques2.9%
  • Urologic and reproductive health conditions2.4%
  • Cancer, Lipids, and Metabolism2%
  • Other47.1%

Coauthors

All papers

Open in search
  1. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2020 cited by 2,814

  2. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2020 cited by 1,126

  3. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean-Philippe Fendler, Hocine Habchi, P. Hallouin, A. Khairoune, Hervé Lang, Y. Lebras, Frédéric Lefèvre, Bernard Malavaud, Paul C. Moldovan, Nicolas Mottet, Pierre Mozer, P. Nevoux, G. Pagnoux, G. Pasticier, D. Portalez, E. Potiron, Athivada Soto Thammavong, Marc‐Olivier Timsit, Arnault Viller, Jochen Walz - The Lancet Oncology 2018 cited by 1,066

  4. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Urology 2016 cited by 3,260

  5. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2018 cited by 517

  6. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Journal of Cancer 2023 cited by 157

  7. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

    Authors: , , , , , , , , , , , , , , - European Urology 2016 cited by 1,442

  8. Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses

    Authors: , , , , , , , , , , - European Urology 2020 cited by 247

  9. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Urology 2017 cited by 533

  10. Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

    Authors: , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2020 cited by 205

  11. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Urology 2022 cited by 118

  12. Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - European Urology Focus 2019 cited by 242

  13. Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sophie Regueme, Caroline Roussillon, Antoine Bénard, Aurore Georget, Astrid Darsonval, Catherine Deneux‐Tharaux - New England Journal of Medicine 2021 cited by 272

  14. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gero Kramer, Chris Logothetis, Fernando Cotait Maluf, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Vedang Murthy, William Oh, Piet Ost, Anwar R. Padhani, Chris Parker, Colin C. Pritchard, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Oliver Sartor, Howard I. Scher, Avishay Sella, Neal D. Shore, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Ian F. Tannock, Bertrand Tombal, R. Valdagni, Thomas Wiegel, Aurelius Omlin - European Urology 2017 cited by 643

  15. Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean Marc Tourani, Camille Serrate, A. Colau, Carolina Saldana, Alexandre de la Taille, Thi Hong Lieu Nguyen, F. Kleinclauss, Yohan LORIOT, Jacques Irani, J.C. Eymard, S. Larré, Olivier Huillard, Marc Zerbib, Frédéric Rolland, J. Rigaud, Nadine Houédé, S. Droupy, Georgina MALOUF, Morgan Rouprêt, S. Vieillot, N. Letang, T. L'Haridon, N. Gaschignard, Werner Hilgers, Jean Louis DAVIN - The Lancet Oncology 2023 cited by 96

  16. Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients

    Authors: , , , , , , , , , , , - European Journal of Cancer 2019 cited by 230

  17. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2017 cited by 390

  18. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer

    Authors: , , , , , , , , , , - European Urology 2013 cited by 1,354

  19. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tobias Gross, Jeremy Grummet, Ann Henry, Alexandre Ingels, Jacques Irani, Michael Lardas, Matthew Liew, Daniel W. Lin, Lisa Moris, Muhammad Imran Omar, Karl H. Pang, Catherine Paterson, Raphaële Renard‐Penna, María J. Ribal, Monique J. Roobol, Morgan Rouprêt, Olivier Rouvière, Gemma Sancho, Jonathan Richenberg, Ivo G. Schoots, J.P. Michiel Sedelaar, Phillip D. Stricker, Derya Tilki, Susanne Vahr Lauridsen, Roderick C.N. van den Bergh, Thomas Van den Broeck, Theodorus van der Kwast, Henk G. van der Poel, Geert J.L.H. van Leenders, Murali Varma, Philippe D. Violette, Christopher J.D. Wallis, Thomas Wiegel, Karen Wilkinson, Fabio Zattoni, James Michael Olu N'Dow, Hendrik Van Poppel, Philip Cornford, Nicolas Mottet - European Urology 2019 cited by 239

  20. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip W. Kantoff, Raja B. Khauli, Raya Leibowitz‐Amit, Chris Logothetis, Fernando Cotait Maluf, Robin Millman, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Hind M’rabti, Declan G. Murphy, Vedang Murthy, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Robert E. Reiter, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Neal D. Shore, Eric J. Small, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Mary-Ellen Taplin, Bertrand Tombal, Levent Türkeri, Inge M. van Oort, A. Zapatero, Aurelius Omlin - European Urology 2020 cited by 395

  21. EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

    Authors: , , , , , , , , , , - European Urology 2013 cited by 1,940

  22. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Celesta Higano, Michael S. Hofman, Maha Hussain, Nick James, Robert J. Jones, Ravindran Kanesvaran, Raja B. Khauli, Laurence Klotz, Raya Leibowitz‐Amit, Chris Logothetis, Fernando Cotait Maluf, Robin Millman, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Hind M’rabti, Declan G. Murphy, Vedang Murthy, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Rob E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Neal D. Shore, Iwona Skoneczna, Eric J. Small, Matthew R. Smith, Howard R. Soule, Daniel E. Spratt, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Mary‐Ellen Taplin, Derya Tilki, Bertrand Tombal, Levent Türkeri, Hiroji Uemura, Hirotsugu Uemura, Inge M. van Oort, Kosj Yamoah, Dingwei Ye, A. Zapatero, Aurelius Omlin - European Urology 2022 cited by 128

  23. Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Van den Broeck, Theodorus van der Kwast, Henk G. van der Poel, Thomas Wiegel, Cathy Yuhong Yuan, Philip Cornford, Nicolas Mottet, Thomas Lam - European Urology 2021 cited by 102

  24. EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Urology Oncology 2022 cited by 40